Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Apple: I’m Not Remarkable
Accessibility features can create new opportunities for people with disabilities.
Seeds of Change Organic Quinoa, Brown & Red Rice
TINA.org reader flags main ingredient fail.
Dave ExtraCash Advance
What you should know about this fast cash offer.
Can You Tell Me How to Pay at Sesame Place?
Theme park fails to adequately disclose that it’s a “cashless” operation.
Did Timothée Chalamet Just Take a Dig at Deceptive Marketing?
Why I’m a fan of this Adidas World Cup ad.